1. Home
  2. DSGN vs ATLO Comparison

DSGN vs ATLO Comparison

Compare DSGN & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$10.64

Market Cap

579.9M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$28.22

Market Cap

239.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSGN
ATLO
Founded
2017
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
579.9M
239.2M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
DSGN
ATLO
Price
$10.64
$28.22
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$15.25
N/A
AVG Volume (30 Days)
252.8K
36.6K
Earning Date
03-09-2026
04-16-2026
Dividend Yield
N/A
2.88%
EPS Growth
N/A
8.03
EPS
N/A
0.38
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$73.18
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$16.09
52 Week High
$11.23
$28.35

Technical Indicators

Market Signals
Indicator
DSGN
ATLO
Relative Strength Index (RSI) 55.47 66.97
Support Level $9.71 $26.00
Resistance Level $11.18 $28.28
Average True Range (ATR) 0.55 0.62
MACD 0.01 0.09
Stochastic Oscillator 63.73 90.42

Price Performance

Historical Comparison
DSGN
ATLO

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

Share on Social Networks: